122 results on '"Jarošová, Marie"'
Search Results
2. Molecular basis of multiple myeloma
3. Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact
4. miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
5. Chromosomal aberrations in childhood acute lymphoblastic leukemia: 15-year single center experience
6. Molecular Cytogenetic Analysis of Chromosome 8 Aberrations in Patients With Multiple Myeloma Examined in 2 Different Stages, at Diagnosis and at Progression/Relapse
7. Duplication of 8q24 in Chronic Lymphocytic Leukemia: Cytogenetic and Molecular Biologic Analysis of MYC Aberrations
8. Cytogenetic and array comparative genomic hybridization analysis of a series of hepatoblastomas
9. Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results
10. Imatinib trough plasma levels do not correlate with the response to therapy in patients with chronic myeloid leukemia in routine clinical setting
11. Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era
12. Imatinib dose escalation in two patients with chronic myeloid leukemia, with low trough imatinib plasma levels measured at various intervals from the beginning of therapy and with suboptimal treatment response, leads to the achievement of higher plasma levels and major molecular response
13. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical and genetic features
14. Recommendations for chronic lymphocytic leukaemia dia gnosis and therapy 2021
15. Treatment of consecutive patients with chronic myeloid leukaemia in the cooperating centres from the Czech Republic and the whole of Slovakia after 2000 – a report from the population-based CAMELIA Registry
16. Chromothripsis – Extensive Chromosomal Rearrangements and Their Significance in Cancer
17. The importance of complex karyotype in prognostication and treatment of chronic lymphocytic leukemia (CLL): a comprehensive review of the literature
18. Plasma Cell Leukemia – the Forgotten Disease
19. Social issues in Humpolec in the period from the second half of the 19th century to the first half of the 20th century
20. Long-term remission of therapy-related acute myeloid leukemia with a new t(11;18)(q23;q21.2) translocation and KMT2A-ME2 (MLL-ME2) fusion gene
21. Integrative Analysis of Pediatric Acute Leukemia Identifies Immature Subtypes That Span a T Lineage and Myeloid Continuum with Distinct Prognoses
22. Kvantitativní uvolňování a riziko růstu inflace v USA
23. Acute myeloid leukemia with minimal differentiation: Unusual cytogenetics, morphology, phenotype and clinical course
24. Rare tetraploidy with large 5q deletion in acute myeloid leukemia with myelodysplasia-related changes (AML-MRC)
25. Molecular Prognostic Markers and Their Clinical Relevance in Chronic Lymphocytic Leukemia
26. A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment
27. SOCIAL SERVICES SYSTEM IN THE ALLOWANCE ORGANIZATION
28. Array comparative genomic hybridization in the detection of chromosomal abnormalities in T-cell prolymphocytic leukemia
29. A novel recurrent chromosomal aberration involving chromosome 7 in childhood myelodysplastic syndrome
30. Major molecular response achieved with dasatinib in a CML patient with F317L BCR-ABL kinase domain mutation
31. Soluble interleukin-2 receptor level predicts survival in patients with follicular lymphoma treated with cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy in the rituximab era
32. Recurrent breakpoints in 14q32.13/TCL1A region in mature B-cell neoplasms with villous lymphocytes
33. Gain of chromosome arm 1q in patieznts in relapse and progression of multiple myeloma
34. Two Novel Mutations in Ribosomal Proteins in the Czech National Diamond-Blackfan Anemia Registry
35. Pathogenetic role ofETV6fusion gene in leukemic transformation of myelodysplastic syndrome refractory anemia with excess blasts-1 with a new, rare translocation t(11;19)(q24.3;q13.12) and insertion ins(6;12)(p22.3p13)
36. 2-[18F]fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation
37. Evaluation of 5‐year imatinib treatment of 458 patients with CP ‐ CML in routine clinical practice and prognostic impact of different BCR ‐ ABL cutoff levels
38. Analýza vztahu volných lehkých řetězců κ/λ a páru těžkých/lehkých řetězců imunoglobulinu ke stratifikaci mnohočetného myelomu podle Mayo Stratification of Myeloma and Revised International Staging System
39. A lower dosage of imatinib is sufficient to maintain undetectable disease in patients with chronic myeloid leukemia with long-term low-grade toxicity of the treatment.
40. Recurrent breakpoints in 14q32.13/TCL1Aregion in mature B-cell neoplasms with villous lymphocytes
41. Operational Cures After Interferon-Alpha in Patients with Chronic Myeloid Leukemia in Central and Northern Moravia
42. Renal oncocytoma with and without intravascular extension into the branches of renal vein have the same morphological, immunohistochemical, and genetic features
43. Clinicopathological correlations of the immunoprofile in diffuse large B-cell lymphoma NOS - a single institution's experience.
44. Intermittent dosage of imatinib mesylate in CML patients with a history of significant hematologic toxicity after standard dosing
45. T-cell gamma/delta hepatosplenic lymphoma - prolonged remission induced by aggressive first line treatment
46. Differences and similarities in kinetics of BCR-ABL transcript levels in CML patients treated with imatinib mesylate for chronic or accelerated disease phase
47. Primary mediastinal (thymic) large B-cell lymphoma with a der(14)t(8;14)(q24;q32) and a translocation of MYC to the derivative chromosome 14 with a deleted IgH locus
48. Pathogenetic role of ETV6 fusion gene in leukemic transformation of myelodysplastic syndrome refractory anemia with excess blasts-1 with a new, rare translocation t(11;19)(q24.3;q13.12) and insertion ins(6;12)(p22.3p13).
49. Využití archivovaných parafínových bločků s formalinem fixovanou tkání (FFPE) pro molekulárně genetickou analýzu u difuzního velkobuněčného lymfomu (DLBCL).
50. 2-[18F]fluoro-2-deoxy- d-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.